These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2371930)

  • 21. [Clinical study of viloxazine (author's transl)].
    Brunner H; Huck F
    Encephale; 1980; 6(3):247-57. PubMed ID: 7449724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synopsis of psychopathological, electroencephalographical, and pharmacokinetic variables during antidepressive treatment with viloxazine (author's transl)].
    Busch H; Bente D; Müller-Oerlinghausen B; Renfordt E
    Arzneimittelforschung; 1978; 28(8):1288-90. PubMed ID: 380579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sequential trial of viloxazine (Vivalan) and imipramine in moderately depressed patients.
    Davies B; Joshua S; Burrows G; Poynton C
    Med J Aust; 1977 Apr; 1(15):521-2. PubMed ID: 875786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Viloxazine: its antidepressant action and lack of concomitant anticholinergic effect].
    Marchetti G; Amaducci L; Faravelli C; Matteini P; Pazzagli A
    Riv Patol Nerv Ment; 1977; 98(2):88-98. PubMed ID: 616014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical experimentation with viloxazine in depressive states].
    Fontan M; Goudemand M; Pellerin-Millecamps E
    Lille Med; 1979 Dec; 24(10):821-4. PubMed ID: 529970
    [No Abstract]   [Full Text] [Related]  

  • 28. Amoxapine and viloxazine: review of the literature with special reference to clinical studies.
    Ban TA
    Psychopharmacol Bull; 1979 Jul; 15(3):22-5. PubMed ID: 386404
    [No Abstract]   [Full Text] [Related]  

  • 29. The therapeutic effect of viloxazine (Vivalan ICI) in hospitalized depressive patients -- a multicenter study.
    Kabes J; Náhunek K; Molcan J; Hynek K; Dostal T; Svestka J; Faltus F; Caplová T
    Act Nerv Super (Praha); 1978 Dec; 20(4):251-2. PubMed ID: 735719
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic use of viloxazine (Vivalan ICI) in depressed hospital out-patients (author's transl)].
    Kabes J; Dostal T
    Cesk Psychiatr; 1976 Dec; 72(6):384-9. PubMed ID: 1000703
    [No Abstract]   [Full Text] [Related]  

  • 31. Viloxazine: assessment of potential rapid antidepressant action.
    Edwards JG
    Br Med J; 1977 Nov; 2(6098):1327. PubMed ID: 338106
    [No Abstract]   [Full Text] [Related]  

  • 32. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double blind comparative trial of viloxazine and amitriptyline in patients suffering from endogenous depression.
    Kiloh LG; Bartrop RW; Franklin JA; Neilson MD
    Aust N Z J Psychiatry; 1979 Dec; 13(4):357-60. PubMed ID: 395939
    [No Abstract]   [Full Text] [Related]  

  • 34. Viloxazine in depressed women: clinical response and cardiovascular effects.
    Corona GL; Frattini P; Cucchi ML; Santagostino G; Schinelli S; Zerbi F; Cairoli S; Tosca P; Savoldi F
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):322-7. PubMed ID: 3623737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The antidepressant viloxazin. A multicenter study under practice conditions].
    Rüther E
    Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the position of viloxazin in the group of antidepressants (author's transl)].
    Náhunek K; Svestka J; Cesková E; Misurec J
    Cesk Psychiatr; 1978 Feb; 74(1):3-8. PubMed ID: 352549
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind trial: vivalan against placebo in depressed elderly patients.
    Von Knorring L
    J Int Med Res; 1980; 8(1):18-21. PubMed ID: 6987113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Third-generation antidepressive agents. Experience with 100 cases of primary depression treated with viloxazine, nomifensine and mianserin].
    Faravelli C; Tonini R; Zaccara G; Marchetti G
    Minerva Psichiatr; 1981; 22(2):79-83. PubMed ID: 7266323
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of schizophrenia without symptoms with viloxazine].
    Kornhuber HH; Lisson G; Rissotto R
    Dtsch Med Wochenschr; 1985 Apr; 110(17):698. PubMed ID: 3886343
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical pharmacokinetics of viloxazine chlorhydrate. Practical implications].
    Bouquet S; Vandel B; Guibert S; Lavoisy J
    Encephale; 1989; 15(5):443-7. PubMed ID: 2686964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.